145 related articles for article (PubMed ID: 31146175)
1. A novel NIR-controlled NO release of sodium nitroprusside-doped Prussian blue nanoparticle for synergistic tumor treatment.
Feng T; Wan J; Li P; Ran H; Chen H; Wang Z; Zhang L
Biomaterials; 2019 Sep; 214():119213. PubMed ID: 31146175
[TBL] [Abstract][Full Text] [Related]
2. Polypyrrole-coated phase-change liquid perfluorocarbon nanoparticles for the visualized photothermal-chemotherapy of breast cancer.
Yang Q; Li P; Ran H; Wan J; Chen H; Chen H; Wang Z; Zhang L
Acta Biomater; 2019 May; 90():337-349. PubMed ID: 30936037
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Therapy Using Doxorubicin-Loading and Nitric Oxide-Generating Hollow Prussian Blue Nanoparticles with Photoacoustic Imaging Potential Against Breast Cancer.
Fu J; Wu Q; Dang Y; Lei X; Feng G; Chen M; Yu XY
Int J Nanomedicine; 2021; 16():6003-6016. PubMed ID: 34511902
[TBL] [Abstract][Full Text] [Related]
4. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
5. A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance.
Peng Y; Nie J; Cheng W; Liu G; Zhu D; Zhang L; Liang C; Mei L; Huang L; Zeng X
Biomater Sci; 2018 May; 6(5):1084-1098. PubMed ID: 29512657
[TBL] [Abstract][Full Text] [Related]
6. Plasmonic MoO
Odda AH; Xu Y; Lin J; Wang G; Ullah N; Zeb A; Liang K; Wen LP; Xu AW
J Mater Chem B; 2019 Mar; 7(12):2032-2042. PubMed ID: 32254807
[TBL] [Abstract][Full Text] [Related]
7. Prussian blue/serum albumin/indocyanine green as a multifunctional nanotheranostic agent for bimodal imaging guided laser mediated combinatorial phototherapy.
Sahu A; Lee JH; Lee HG; Jeong YY; Tae G
J Control Release; 2016 Aug; 236():90-9. PubMed ID: 27349352
[TBL] [Abstract][Full Text] [Related]
8. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
Lin X; Cao Y; Li J; Zheng D; Lan S; Xue Y; Yu F; Wu M; Zhu X
Biomater Sci; 2019 Jul; 7(7):2996-3006. PubMed ID: 31111139
[TBL] [Abstract][Full Text] [Related]
9. NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform.
Shen X; Li T; Chen Z; Xie X; Zhang H; Feng Y; Li S; Qin X; Yang H; Wu C; Zheng C; Zhu J; You F; Liu Y
Mol Pharm; 2019 Mar; 16(3):1367-1384. PubMed ID: 30776896
[TBL] [Abstract][Full Text] [Related]
10. Multi-stimuli responsive mesoporous carbon nano-platform gated by human serum albumin for cancer thermo-chemotherapy.
Zhao Q; Wang X; Yang M; Li X; Mao Y; Guan X; Di D; Wang S
Colloids Surf B Biointerfaces; 2019 Dec; 184():110532. PubMed ID: 31590051
[TBL] [Abstract][Full Text] [Related]
11. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
12. H
Yu Y; Zhang L; Wang M; Yang Z; Lin L; Xiong Y; Xu Z; Wang J
Nanomedicine (Lond); 2019 Aug; 14(16):2189-2207. PubMed ID: 31411542
[No Abstract] [Full Text] [Related]
13. Nanographene oxide-methylene blue as phototherapies platform for breast tumor ablation and metastasis prevention in a syngeneic orthotopic murine model.
Dos Santos MSC; Gouvêa AL; de Moura LD; Paterno LG; de Souza PEN; Bastos AP; Damasceno EAM; Veiga-Souza FH; de Azevedo RB; Báo SN
J Nanobiotechnology; 2018 Jan; 16(1):9. PubMed ID: 29382332
[TBL] [Abstract][Full Text] [Related]
14. Laser-Induced Transformable BiS@HSA/DTX Multiple Nanorods for Photoacoustic/Computed Tomography Dual-Modal Imaging Guided Photothermal/Chemo Combinatorial Anticancer Therapy.
Guo W; Chen J; Liu L; Eltahan AS; Rosato N; Yu J; Wang D; Chen J; Bottini M; Liang XJ
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41167-41177. PubMed ID: 30406646
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
Lian H; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
[TBL] [Abstract][Full Text] [Related]
16. Prussian blue-coated lanthanide-doped core/shell/shell nanocrystals for NIR-II image-guided photothermal therapy.
Wang X; Li H; Li F; Han X; Chen G
Nanoscale; 2019 Nov; 11(45):22079-22088. PubMed ID: 31720650
[TBL] [Abstract][Full Text] [Related]
17. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
18. Bubble-generating polymersomes loaded with both indocyanine green and doxorubicin for effective chemotherapy combined with photothermal therapy.
Zhu D; Fan F; Huang C; Zhang Z; Qin Y; Lu L; Wang H; Jin X; Zhao H; Yang H; Zhang C; Yang J; Liu Z; Sun H; Leng X; Kong D; Zhang L
Acta Biomater; 2018 Jul; 75():386-397. PubMed ID: 29793073
[TBL] [Abstract][Full Text] [Related]
19. Prussian blue-modified ferritin nanoparticles for effective tumor chemo-photothermal combination therapy via enhancing reactive oxygen species production.
Li H; Zhang W; Ding L; Li XW; Wu Y; Tang JH
J Biomater Appl; 2019 Apr; 33(9):1202-1213. PubMed ID: 30714472
[TBL] [Abstract][Full Text] [Related]
20. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
